Real-world clinical outcomes among patients with advanced non-small cell lung cancer who initiated first-line regimens

被引：0
|
作者：
Nadler, Eric [1 ]
Arondekar, Bhakti
Aguilar, Kathleen [2 ]
Zhou, Jie [2 ]
Chang, Jane
Zhang, Xinke [3 ,4 ]
Pawar, Vivek [3 ,4 ]
机构：
[1] Texas Oncol, Med Oncol, Dallas, TX USA
[2] Pfizer Inc, New York, NY USA
[3] McKesson Life Sci, The Woodlands, TX USA
[4] EMD Serono Inc, Billerica, MA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P321
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-World Outcomes of Immunotherapy-Based Regimens in First-Line Advanced Non-Small Cell Lung Cancer
    Waterhouse, D.
    Lam, J.
    Betts, K. A.
    Yin, L.
    Gao, S.
    Yuan, Y.
    Hartman, J.
    Rao, S.
    Lubinga, S.
    Stenehjem, D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S17 - S18
  • [2] Real-world outcomes of immunotherapy-based regimens in first-line advanced non-small cell lung cancer
    Waterhouse, David
    Lam, Jenny
    Betts, Keith A.
    Yin, Lei
    Gao, Sophie
    Yuan, Yong
    Hartman, John
    Rao, Sumati
    Lubinga, Solomon
    Stenehjem, David
    [J]. LUNG CANCER, 2021, 156 : 41 - 49
  • [3] Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer
    Pelicon, Veronika
    Cufer, Tanja
    Knez, Lea
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [4] Real-World Outcomes and Value of First-Line Therapy for Metastatic Non-Small Cell Lung Cancer†
    Byfield, Stacey DaCosta
    Chastek, Benjamin
    Korrer, Stephanie
    Horstman, Thomas
    Malin, Jennifer
    Newcomer, Lee
    [J]. CANCER INVESTIGATION, 2020, 38 (10) : 608 - 617
  • [5] Clinical outcomes among patients with advanced non-small cell lung cancer who received targeted therapy in a real-world setting
    Yang, Mo
    MacEwan, Joanna P.
    Boppudi, Sai Sriteja
    McClain, Monica
    O'Hara, Richard
    Liu, Frank
    Paik, Paul K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Impact of Frailty on Outcomes of First-Line Pembrolizumab Monotherapy in a Real-World Population with Advanced Non-Small Cell Lung Cancer
    Galan, Rocio Jimenez
    Prado-Mel, Elena
    de Sotomayor, Maria Alvarez
    Martin, Laila Abdel-Kader
    [J]. BIOLOGY-BASEL, 2023, 12 (02):
  • [7] Clinical Outcomes of First-line Therapies for Advanced Non-Small Cell Lung Cancer
    Garcia-Fumero, Ricardo
    Fernandez-Lopez, Cristina
    Calleja-Hernandez, Miguel angel
    Exposito-Ruiz, Manuela
    Espin, Jaime
    Exposito-Hernandez, Jose
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (10): : 433 - 438
  • [8] Real-World Experience of First-Line Afatinib Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer
    Liam, C.
    Ho, G.
    Chai, C.
    Alip, A. Bt
    Pang, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S998 - S999
  • [9] Real-World Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer (aNSCLC) in the US
    Nadler, E.
    Chang, J.
    Zhang, X.
    Aguilar, K.
    Zhou, J.
    Arondekar, B.
    Pawar, V.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S38 - S39
  • [10] Real-world outcomes of immunotherapy regimens in first line non small cell lung cancer in lebanese patients.
    Nasr, Lewis
    Diab, Saada
    Ghoche, Ahmad
    Yehia, Intissar
    Nasr, Fadi Louis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18741 - E18741
12345